Companies: 10,795·Total market cap: $144.5T
Mallinckrodt plc

Mallinckrodt plc

MNKAMEXHealthcare
$0.34
$-0.06(-14.97%)
Market Cap$4520986
P/E Ratio
52W High$16.0
52W Low$0.3

Mallinckrodt plc (MNK) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · MNK · as of Apr 15, 2026

Latest filing snapshot

1,600
-1,100-40.74%vs prior year

Mallinckrodt plc (MNK) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
1,600
Change (1Y)
-1,100
Growth % (1Y)
-40.74%
Revenue / Employee
$894.1K
Net Income / Employee
$-305.9K
Market Cap
$5M

MNK Employee Count

2022 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-04-151,600-1,100-40.74%
2025-03-132,700-100-3.57%
2024-03-262,800+100+3.70%
2023-03-032,700

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Drug Manufacturers - Specialty & Generic
#SymbolCompanyEmployees
#1
Mallinckrodt plc
MNK
Mallinckrodt plcYOU
1,600
#2
Gamida Cell Ltd.
GMDA
Gamida Cell Ltd.
143
#3
Nabriva Therapeutics plc
NBRVF
Nabriva Therapeutics plc
39
#4
Xylo Technologies Ltd.
MDGS
Xylo Technologies Ltd.
38
#5
Aptose Biosciences Inc.
APTO
Aptose Biosciences Inc.
35
#6
BiondVax Pharmaceuticals Ltd.
BVXV
BiondVax Pharmaceuticals Ltd.
33
#7
Hillstream BioPharma, Inc.
HILS
Hillstream BioPharma, Inc.
1
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · MNK peer comparison

About MNK employees

MNK Employees · Headcount

Mallinckrodt plc (MNK) employee data is sourced from the annual SEC 10-K filing. As of 2025, Mallinckrodt plc had 1,600 full-time employees globally. Full-time employees only. Global consolidated headcount.

Mallinckrodt plc employs 1,600 full-time employees as of the latest filing within the Drug Manufacturers - Specialty & Generic industry. Revenue per employee stands at $894,125, reflecting the company's operational efficiency.

Mallinckrodt plc's workforce decreased by 1,100 (40.74%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Mallinckrodt plc's revenue per employee of $894,125 positions it among the notable performers in the Drug Manufacturers - Specialty & Generic sector for operational efficiency.

Frequently Asked Questions

MNK Employees · 5 questions

As of the latest SEC 10-K filing (2025), Mallinckrodt plc had 1,600 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Mallinckrodt plc employee counthow many employees does Mallinckrodt plc haveMNK total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-04-15